ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 570,20
-0,77%
Dow Jones
38 834,86
0,15%
DAX
18 067,91
-0,31%
Brent Oil
84,695
-0,11%
Bitcoin
64 814,52
-0,50%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Zynerba Pharmaceuticals Inc (ZYNE)

  7. Zynerba Pharmaceuticals Inc (ZYNE) Actualités

ZYNE Zynerba Pharmaceuticals Inc

1,30
0,00 (0,00%)
18 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Zynerba Pharmaceuticals Inc ZYNE NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 1,30 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,30 1,30
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
09/2/202401:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/10/202322:48EDGAR2Form 15-12G - Securities registration termination [Section..
12/10/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
11/10/202316:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202316:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202315:27EDGAR2Form POS AM - Post-Effective amendments for registration..
11/10/202315:27EDGAR2Form S-8 POS - Securities to be offered to employees in..
11/10/202314:56EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
11/10/202314:31EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
11/10/202314:17EDGAR2Form 8-K - Current report
11/10/202314:00PRNUSHARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA..
04/10/202323:29EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
04/10/202322:05GLOBEImportant Information for Zynerba Pharmaceuticals..
29/9/202315:00GLOBEZynerba Pharmaceuticals Stockholders Reminded to Tender..
27/9/202314:25EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
27/9/202314:12EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
27/9/202314:00PRNUSHARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO..
15/9/202314:00EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
14/9/202322:59EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
14/9/202322:16EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
14/9/202322:15GLOBEZynerba Pharmaceuticals Presents Positive Data from Phase 2..
14/9/202322:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202322:39EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/8/202322:05EDGAR2Form 8-K - Current report
28/8/202315:05EDGAR2Form SC 14D9 - Solicitation, recommendation statements
28/8/202314:23EDGAR2Form SC TO-T - Tender offer statement by Third Party
24/8/202323:23EDGAR2Form SC 13D - General statement of acquisition of beneficial..
15/8/202322:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/8/202323:29EDGAR2Form SC TO-C - Written communication relating to an issuer..
14/8/202323:26EDGAR2Form SC TO-C - Written communication relating to an issuer..
14/8/202323:20EDGAR2Form SC14D9C - Written communication relating to third party..
14/8/202313:45EDGAR2Form SC14D9C - Written communication relating to third party..
14/8/202313:42EDGAR2Form 8-K - Current report
14/8/202313:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202313:30PRNUSHARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.
08/8/202322:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/8/202322:05GLOBEZynerba Pharmaceuticals Announces New Date for Reconvened..
25/7/202323:24EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
25/7/202323:18GLOBEZynerba Pharmaceuticals Announces New Date for Reconvened..
28/6/202322:21EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/6/202322:05GLOBEZynerba Pharmaceuticals Announces Further Adjournment of..
20/6/202313:00GLOBEZynerba Pharmaceuticals to Present at the H.C. Wainwright..

Dernières Valeurs Consultées

NASDAQ
ZYNE
Zynerba Pharmaceuticals
COIN
CLIQETH
Cliq
BIT
NSCIT5445308
International Airlines
BIT
P204K2
NLBNPIT204K2 20991231 23...
NASDAQI
OMXB10GI
OMX Baltic 10 GI
LSE
96GE
Bahia 5%1913
BIT
P1UOZ7
NLBNPIT1UOZ7 20240621 130
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés